Clari Vest Asset Management LLC Altimmune, Inc. Transaction History

Clari Vest Asset Management LLC

  • $1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$8.74 - $16.45 $6,118 - $11,515
-700 Reduced 1.84%
37,400 $615,000
Q3 2022

Nov 10, 2022
SELL
$10.67 - $22.41 $69,355 - $145,665
-6,500 Reduced 14.57%
38,100 $487,000
Q2 2022

Aug 12, 2022
BUY
$3.94 - $11.77 $175,724 - $524,942
44,600 New
44,600 $522,000

Others Institutions Holding ALT

# of Institutions
208
Shares Held
39.5M
Call Options Held
1.94M
Put Options Held
1.38M
View Full List

About Altimmune, Inc.

ALT Quotes by TradingView
  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $315M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email